10% owner HRT Financial LP sells net 28,847 shares amid 65.5% 90-day decline; stock -95.2% from 52-week high.
HRT Financial LP executed 2 separate transactions on consecutive days: a purchase of 25,791 shares at $1.11 on 2026-06-30 and a sale of 54,638 shares at $1.44 on 2026-07-01, resulting in a net reduction of 28,847 shares (-61.7% vs pre-transaction holdings). The sale occurred at $1.44 while current price stands at $1.07, indicating the sold shares appreciated modestly intraday before the broader decline. The fundamental backdrop is acute: revenue contracted 30.0% year-over-year, the company posted net income of -$5,885,315.00, and market cap is $670,740.20—indicating severe distress. The stock has declined 65.5% over the past 90 days and sits 95.2% below its 52-week high of $22.40, signaling a company in crisis. The insider's cross-ticker track record shows 14 prior buys against 6 prior sells, yet this filing contains both purchase and sale activity in rapid succession—the sale dwarfs the purchase by 54.6K shares versus 25.8K shares, and at higher proceeds ($78,678.72 vs $28,628.01). This pattern occurs as the stock approaches distressed valuations in an unprofitable, declining-revenue environment.